Parkinson's Disease Trial, Recruiting NCT06225830 Sponsor: Albert Einstein Healthcare Network Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06225830
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's with no known cause) by a doctor
  • People at any stage of Parkinson's disease
  • People who are able to give their own consent to take part in a research study
  • People who are willing to take part in 45–60 minutes of high-intensity walking and physical therapy sessions
  • People who have enough arm and hand strength to use a front-wheeled walker
  • People who report having difficulties with walking or balance
  • People who are over 18 years of age
  • People who are able to remain upright for at least 15 minutes
  • People who weigh 220 pounds (100 kg) or less
  • People whose height is approximately between 5'0" and 6'4"
  • People who have near-normal movement in their hips, knees, and ankles — for example, those who can straighten their knees fully, even briefly, either while standing or lying flat

Who may not be able to join:

  • People who are currently taking part in another research intervention study or a separate course of physical therapy
  • People who have another neurological condition in addition to Parkinson's disease
  • People who report having a difference in leg length between their two legs
  • People with an unstable spine
  • People with an unresolved blood clot in a deep vein (such as in the leg)
  • People experiencing severe muscle or bone pain
  • People with open skin sores on the buttocks or other areas of the body that would be in contact with the exoskeleton device or harness used in the study
  • People who are pregnant
  • People who have cognitive difficulties that prevent them from following two-step instructions or communicating if they are in pain or need to stop
  • People who need more than one therapist to help them move safely from one position to another
  • People with uncontrolled or severe drops in blood pressure when moving from sitting to standing, causing ongoing symptoms
  • People with certain bone or joint conditions, including active abnormal bone growth (confirm with trial site), hip dysplasia, or abnormal alignment of the hip or knee
  • People who have a colostomy bag
  • People who have a history of long bone fractures caused by osteoporosis
  • People whose Parkinson's medication has changed in the past week, or who are unable to keep their current medication routine stable
  • People whom the treating therapist considers it would be unsafe to enrol or continue in the study, for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jacqueline Brown, DPT, Albert Einstein Healthcare Network

Phone: 215-663-6575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Albert Einstein Healthcare Network
Registry
ClinicalTrials.gov
Start date
4 June 2024
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Steps per session & progression through protocol

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov